Search results
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 3 days agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
California State Teachers Retirement System Increases Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 4 days agoCalifornia State Teachers Retirement System grew its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 1.5% during the fourth quarter, according to its most recent 13F filing ...
Strong trial results for Pfizer lung cancer drug | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 7 days agoA Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes...
Pfizer's drug for advanced lung cancer shows promising long-term trial results
CNBC· 7 days agoPfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term...
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Morningstar· 4 days agoPfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Goldman ...
Pfizer Inc. (NYSE:PFE) – Experts See The Stock A Different Way Today – Marketing Sentinel
Marketing Sentinel· 2 days agoIn today’s recent session, 11.85 million shares of the Pfizer Inc. (NYSE:PFE) have been traded, and its beta is 0.67. Most recently the company’s share price was $29.38, and ...
NJ health care, pharmaceutical companies cutting jobs as tech disrupts industry
The Bergen Record via Yahoo News· 3 hours agoNationally, small to medium-sized drugmakers cut at least 10,000 jobs in 2023, according to an...
How To Earn $500 A Month From Pfizer Stock
Benzinga· 7 days agoShares of Pfizer Inc. PFE closed higher during Thursday's session, with the company's stock adding around 10% over the past month. Pfizer recently...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 15 hours agoPfizer and Moderna are also planning to prepare JN.1-focused boosters. Novavax stock has been on a...
Pfizer's LORBRENA shows sustained NSCLC patient benefit over five years By Investing.com
Investing.com· 7 days agoPfizer Inc. (NYSE: NYSE:PFE) has released new data from its Phase 3 CROWN trial, which shows a...